Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 01, 2008 | Senior VP, Drug Development | Open market or private sale of non-derivative or derivative security | Form 4 | 142 | $11.25 | 42,116 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 100 | $10.19 | 916,024 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,400 | $10.20 | 917,424 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 340 | $10.21 | 917,764 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 200 | $10.22 | 917,964 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,400 | $10.23 | 919,364 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 100 | $10.27 | 919,464 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 100 | $10.30 | 919,564 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 5 | $10.32 | 919,569 | |
| Mar 10, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 30 | $10.35 | 919,599 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.